A Single-centre, Open-label, Randomised, Crossover, Drug-drug Interaction Study to Investigate the Effect of a Single Oral Dose of Ritonavir on the Single Dose Pharmacokinetics of ASP2151 in Healthy Men
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2014
At a glance
- Drugs Amenamevir (Primary) ; Ritonavir
- Indications Herpes simplex virus infections; Herpes zoster
- Focus Pharmacokinetics
- 09 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 25 Aug 2014 New trial record